Humans and mice exposed to long-wavelength red light had lower rates of blood clots that can cause heart attacks, lung damage ...

Oxford Cancer Analytics (OXcan) has secured $11m in Series A funding for the development of its liquid biopsy blood tests for ...

New research from the University of St Andrews School of Medicine has found that biomarker testing in individuals at risk of ...

“Bev has significant kyphoscoliosis (curvature of the spine that’s both sideways and forward/backward), which made the biopsy ...

You can become addicted to nicotine within days of starting to use it, even if you only vape occasionally. Here's how to tell ...

OXcan was founded in 2020 by Dr. Peter Jianrui Liu and Dr. Andreas Halner to advance early cancer detection using liquid biopsy.

The blood test for those at high risk of lung cancer could lead to earlier detection and a "major reduction" in deaths, a ...

Researchers at the Francis Crick Institute, the UCL Cancer Institute and UCLH have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used ...

Oxford Cancer Analytics (OXcan), the medtech company developing blood tests for early cancer detection using advanced proteomics and AI, today announced it has raised US$11 million in Series A funding ...

This latest investment, which brings OXcan’s total funding to date to $16.7 million, will be used to develop and globally ...

Researchers at the Francis Crick Institute, the UCL Cancer Institute and UCLH have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used ...

Biomarkers found in the blood can reveal changes in the body that may signal lung cancer before symptoms appear.